Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP): a single center, open-label, three-arm, randomized, controlled intervention trial

Liver cirrhosis is a major healthcare problem and the mortality rate is high. During recent years, systemic inflammation has been recognized as a major driver of hepatic decompensation and progression of liver cirrhosis to acute-on-chronic liver failure (ACLF). The aim of the CYTOHEP study is to ass...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sekandarzad, Asieb (VerfasserIn) , Weber, Enya (VerfasserIn) , Prager, Eric Peter (VerfasserIn) , Graf, Erika (VerfasserIn) , Bettinger, Dominik (VerfasserIn) , Wengenmayer, Tobias (VerfasserIn) , Supady, Alexander (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 18 March 2022
In: Trials
Year: 2022, Jahrgang: 23, Pages: 1-20
ISSN:1468-6694
DOI:10.1186/s13063-022-06139-6
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13063-022-06139-6
Volltext
Verfasserangaben:Asieb Sekandarzad, Enya Weber, Eric Peter Prager, Erika Graf, Dominik Bettinger, Tobias Wengenmayer and Alexander Supady
Beschreibung
Zusammenfassung:Liver cirrhosis is a major healthcare problem and the mortality rate is high. During recent years, systemic inflammation has been recognized as a major driver of hepatic decompensation and progression of liver cirrhosis to acute-on-chronic liver failure (ACLF). The aim of the CYTOHEP study is to assess the impact of extracorporeal hemoadsorption with the CytoSorb adsorber on serum bilirubin concentrations, humoral inflammation parameters, liver function parameters, and patient survival in patients with ACLF and acute kidney injury (AKI).
Beschreibung:Gesehen am 13.05.2022
Beschreibung:Online Resource
ISSN:1468-6694
DOI:10.1186/s13063-022-06139-6